Sign inJoin waitlistJoin the waitlist

Jack Rubinstein

Program Director, Clinical Scientist Training Program · University of Cincinnati Medical Center Inc.

Credentials: · · · · · ·

History

Clinical Scientist Training Program · University of Cincinnati Medical Center Inc.
Present
IMSTAR · University of Cincinnati Medical Center Inc.
Present
Physician Scientist Training Program · University of Cincinnati College of Medicine
Present

Instituto Nacional de Cardiologia Ignacio Chavez
2009–2010
Cardiovascular Disease
Michigan State University
2006–2009
Internal Medicine
Jefferson Health Medical Education
2003–2006
Internal Medicine
University of Cincinnati Medical Center Inc.
2000–2003
Universidad Anahuac del Norte
1996–2000
University of Cincinnati

Research

The history and future of probenecid
Review · Cardiovascular Toxicology · 2012 · Last of 4 authors · 117 citations
Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation
Journal of Molecular and Cellular Cardiology · 2012 · Last of 16 authors · 74 citations
Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale
Journal of the American Geriatrics Society · 2023 · 74 citations

NR
Nathan Robbins
22 papers · 1 as a resident
Ahmad Anjak
6 papers · 1 as a resident
George Abela
6 papers
Roger Hajjar
5 papers
Neal Weintraub
4 papers
Daniel Schauer
3 papers
RK
Rajiv Karani
3 papers
Samuel Slone
3 papers · 3 as a resident
AP
Alejandro Prieto
2 papers
AV
Ameeth Vedre
2 papers · 1 as a fellow
CT
Charuhas Thakar
2 papers
Deidra Crews
2 papers

Grants

Stimulating Access to Research in the University of Cincinnati Internal Medicine Residency Program
National Heart, Lung, and Blood Institute · R38
Contact PI · $1.6M · University of Cincinnati
2021–2030
Treatment of Veterans with Heart Failure with Reduced Ejection Fraction with Probenecid
Department of Veterans Affairs · I01
Contact PI · Cincinnati Va Medical Center Research
2021–2026
Endocrine Disruptors and Heart Health
National Institute of Environmental Health Sciences · R01
PI · $2.1M · University of Cincinnati
2018–2024
Gene-Environment Interactions in the Fetal Origin of Adult Cardiac Disease
National Institute of Environmental Health Sciences · R01
PI · $2.4M · University of Cincinnati
2014–2021

Clinical trials

The Re-Prosper HF Study
Principal investigator · Completed · Phase 2, Phase 3
VA Office of Research and Development
2021–2025
An Advanced Echocardiographic Evaluation of Nebivolol
Principal investigator · Terminated · Phase 4
Jack Rubinstein
2010–2012
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
Site PI · Recruiting · Phase 4
Duke University
2020–2026